• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ETHICON INC. STRATAFIX UNKNOWN; SUTURE, SURGICAL, ABSORBABLE, (POLIGLECAPRONE 25)

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ETHICON INC. STRATAFIX UNKNOWN; SUTURE, SURGICAL, ABSORBABLE, (POLIGLECAPRONE 25) Back to Search Results
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Dysphagia/ Odynophagia (1815)
Event Date 06/19/2021
Event Type  Injury  
Manufacturer Narrative
Product complaint # (b)(4).This is a combination product, and the event has been reviewed for both the suture and the triclosan.Trade name - irgacare®, active ingredient(s) ¿ triclosan, dosage form ¿ suture/solid/parenteral, strength ¿ = 2360 g/m all others.The following information was requested, but unavailable: does the author/ surgeon believe that ethicon products (vicryl plus suture) involved caused and/or contributed to post-op complications (anastomotic stricture/ dysphagia (n=2)) described in the article? please specify.Does the author/ surgeon believe there was any deficiency with the ethicon products (vicryl plus suture) used for cases described in this study? if yes, please provide a complete patient demographics for patients with post-op complication (anastomotic stricture/ dysphagia)? were all these cases discussed in this article previously reported to ethicon? if yes, please provide a complaint reference number.No additional information can be provided.Please clarify what exactly type of stratafix suture was used in this study.No additional information can be provided.This report is related to a journal article; therefore, no product will be returned for analysis and the batch history records cannot be reviewed as the lot number has not been provided.(b)(4).The single complaint was reported with multiple events.There are no additional details regarding the additional events.Related event captured via 2210968-2021-08906.Citation: journal of thoracic disease (2021);13(7):4349-4359.Doi: 10.21037/jtd-21-438.
 
Event Description
Title: pretreatment-assisted robot intrathoracic layered anastomosis: our exploration in ivor-lewis esophagectomy.The aim of this retrospective study is to report our early experience in miile using prila and describe the technical innovations made in response to intraoperative challenges.A total of 43 patients (33 males and 10 females; mean age of 62.60±7.135 years; mean bmi of 21.9±2.45) underwent minimal invasive ivor-lewis esophagectomy (miile) using the series technique called pretreatment-assisted robot intrathoracic layered anastomosis (prila) with curative intent for a biopsy proved esophageal malignancy between september 2018 and december 2020.A 4 cm-wide gastric conduit was constructed using a linear stapler (ec60g, j&j, usa).Suturing of the posterior esophageal muscular layer and the posterior seromuscular layer of the conduit using a 3-0 barbed suture (stratafix, j&j co., usa), the posterior esophageal mucosa and the posterior mucosa of the conduit with 4/0 vicryl plus antibacterial suture (j&j co., usa), the anterior mucosa with another 4/0 vicryl plus antibacterial suture, and the anterior muscular layer with another 3-0 barbed suture (stratafix, j&j co., usa).Reported complications include anastomotic stricture/ dysphagia (n=2), by placing the duodenal feeding tube and one endoscopic balloon dilatation, the patients gradually returned to normal diet.In conclusion, the series technique of prila further streamlines and visualizes the process of intrathoracic ega, thus ensuring the precise anastomosis, which would be a feasible alternative for intrathoracic ega in miile.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
STRATAFIX UNKNOWN
Type of Device
SUTURE, SURGICAL, ABSORBABLE, (POLIGLECAPRONE 25)
Manufacturer (Section D)
ETHICON INC.
1000 route 202
raritan NJ 08869
Manufacturer (Section G)
ETHICON INC.
Manufacturer Contact
elba bello
1000 route 202
raritan, NJ 08869
MDR Report Key12918979
MDR Text Key285627048
Report Number2210968-2021-12296
Device Sequence Number1
Product Code NEW
Combination Product (y/n)Y
Reporter Country CodeCH
PMA/PMN Number
NA
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Literature,Health Professional
Reporter Occupation Other
Type of Report Initial
Report Date 12/02/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/02/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Was Device Available for Evaluation? No
Date Manufacturer Received11/12/2021
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-